Franklin Resources Inc 2seventy Bio, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.09 - $6.0 $32,862 - $63,810	10,635 New	10,635 $56,000
Q2 2023 Aug 11, 2023	BUY	$8.45 - $12.48 $169 - $249	20 Added 0.16%	12,661 $128,000
Q1 2023 May 12, 2023	BUY	$9.21 - $14.98 $116,423 - $189,362	12,641 New	12,641 $128,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.